The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Alzheimer’s disease pathogenesis and therapeutic interventions
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Mitochondrial free radical generation, oxidative stress, and aging
Cadenas, E., & Davies, K. J. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00317-8 · Cited by 3,010
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Candidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Wolfe, M. S., Xia, W., Ostaszewski, B. L., Diehl, T. S., Kimberly, W. T., & Selkoe, D. J. (1999) · Nature · doi:10.1038/19077 · Cited by 1,916
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777
Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757
Harper, J. D., & Lansbury, P. T. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.385 · Cited by 1,652
Apoptosis in neurodegenerative disorders
Mattson, M. P. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35040009 · Cited by 1,605
Oxidative stress and gene regulation
Allen, R. G., & Tresini, M. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00242-7 · Cited by 1,302
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Translating cell biology into therapeutic advances in Alzheimer's disease
Selkoe, D. J. (1999) · Nature · doi:10.1038/399a023 · Cited by 1,166
Apolipoprotein E polymorphism and Alzheimer's disease
Poirier, J., Bertrand, P., Poirier, J., Kogan, S., Gauthier, S., Poirier, J., Gauthier, S., Davignon, J., Bouthillier, D., & Davignon, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)91705-q · Cited by 1,108
Metalloproteinases in biology and pathology of the nervous system
Yong, V. W., Power, C., Forsyth, P., & Edwards, D. R. (2001) · Nature Reviews Neuroscience · doi:10.1038/35081571 · Cited by 1,060
Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease
Mecocci, P., MacGarvey, U., & Beal, M. F. (1994) · Annals of Neurology · doi:10.1002/ana.410360510 · Cited by 1,037
S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death
Gu, Z., Kaul, M., Yan, B., Kridel, S. J., Cui, J., Strongin, A., Smith, J. W., Liddington, R. C., & Lipton, S. A. (2002) · Science · doi:10.1126/science.1073634 · Cited by 950
Oxidative damage in Alzheimer's
Smith, M. A., Perry, G., Richey, P. L., Sayrec, L. M., Anderson, V. E., Beal, M. F., & Kowall, N. (1996) · Nature · doi:10.1038/382120b0 · Cited by 894
Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age
Corral-Debrinski, M., Horton, T., Lott, M. T., Shoffner, J. M., Flint Beal, M., & Wallace, D. C. (1992) · Nature Genetics · doi:10.1038/ng1292-324 · Cited by 890
McGeer, P. L., Itagaki, S., Tago, H., & McGeer, E. G. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90696-3 · Cited by 836
Complement activation by beta-amyloid in Alzheimer disease.
Rogers, J., Cooper, N. R., Webster, S., Schultz, J., McGeer, P. L., Styren, S. D., Civin, W. H., Brachova, L., Bradt, B., & Ward, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10016 · Cited by 817
Oxidative processes and antioxidative defense mechanisms in the aging brain 1
Reiter, R. J. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.7.7737461 · Cited by 806
Turner, P. R., O’Connor, K., Tate, W. P., & Abraham, W. C. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00089-3 · Cited by 756
Auld, D. S., Kornecook, T. J., Bastianetto, S., & Quirion, R. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00079-5 · Cited by 666
Evidence of neuronal oxidative damage in Alzheimer's disease.
Good, P. F., Werner, P., Hsu, A., Olanow, C. W., & Perl, D. P. (1996) · Europe PMC (PubMed Central) · Cited by 663
CNS energy metabolism as related to function
Ames, A. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00038-2 · Cited by 663
Lovell, M. A., Ehmann, W. D., Butler, S. M., & Markesbery, W. R. (1995) · Neurology · doi:10.1212/wnl.45.8.1594 · Cited by 644
Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides
Xu, H., Gouras, G. K., Greenfield, J. P., Vincent, B., Naslund, J., Mazzarelli, L., Fried, G., Jovanovic, J. N., Seeger, M., Relkin, N. R., et al. (1998) · Nature Medicine · doi:10.1038/nm0498-447 · Cited by 560
Kovacs, D. M., Fausett, H. J., Page, K. J., Kim, T.-W., Moir, R. D., Merriam, D. E., Hollister, R. D., Hallmark, O. G., Mancini, R., Felsenstein, K. M., et al. (1996) · Nature Medicine · doi:10.1038/nm0296-224 · Cited by 551
Oxidative damage to DNA in mammalian chromatin
Dizdaroglu, M. (1992) · Mutation Research/DNAging · doi:10.1016/0921-8734(92)90036-o · Cited by 545
Lyras, L., Cairns, N. J., Jenner, A., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052061.x · Cited by 531
Aging renders the brain vulnerable to amyloid β-protein neurotoxicity
Guela, C., Wu, C.-K., Saroff, D., Lorenzo, A., Yuan, M., & Yankner, B. A. (1998) · Nature Medicine · doi:10.1038/nm0798-827 · Cited by 520
Alzheimer's disease – do tauists and baptists finally shake hands?
Mudher, A., & Lovestone, S. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02031-2 · Cited by 514
Electron transport chain defects in Alzheimer's disease brain
Parker, W. D., BA, J. P., Filley, C. M., & Kleinschmidt-DeMasters, B. K. (1994) · Neurology · doi:10.1212/wnl.44.6.1090 · Cited by 494
Ameboid microglia as effectors of inflammation in the central nervous system
Giulian, D. (1987) · Journal of Neuroscience Research · doi:10.1002/jnr.490180123 · Cited by 482
Selkoe (1999) · doi:10.1038/19866 · Cited by 468
Inflammatory Neurodegeneration Mediated by Nitric Oxide, Glutamate, and Mitochondria
Brown, G. C., & Bal-Price, A. (2003) · Molecular Neurobiology · doi:10.1385/mn:27:3:325 · Cited by 461
Spina, M. B., Squinto, S. P., Miller, J., Lindsay, R. M., & Hyman, C. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08880.x · Cited by 460
Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning
Schenk, D. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn938 · Cited by 436
Neurodegenerative disorders: the role of peroxynitrite
Torreilles, F., Salman-Tabcheh, S., Guérin, M.-C., & Torreilles, J. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00014-4 · Cited by 430
McLaurin, J., Cecal, R., Kierstead, M. E., Tian, X., Phinney, A. L., Manea, M., French, J. E., Lambermon, M. H. L., Darabie, A. A., Brown, M. E., et al. (2002) · Nature Medicine · doi:10.1038/nm790 · Cited by 412
Presenilin 1 associates with glycogen synthase kinase-3β and its substrate tau
Takashima, A., Murayama, M., Murayama, O., Kohno, T., Honda, T., Yasutake, K., Nihonmatsu, N., Mercken, M., Yamaguchi, H., Sugihara, S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9637 · Cited by 409
A detergent-insoluble membrance compartment contains Aβ in vivo
Lee, S.-J., Liyanage, U., Bickel, P. E., Xia, W., Lansbury, P. T., & Kosik, K. S. (1998) · Nature Medicine · doi:10.1038/nm0698-730 · Cited by 395
Pivotal Role of Mitochondrial Calcium Uptake in Neural Cell Apoptosis and Necrosis
Kruman, I. I., & Mattson, M. P. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720529.x · Cited by 355
Buxbaum, J. D., Choi, E.-K., Luo, Y., Lilliehook, C., Crowley, A. C., Merriam, D. E., & Wasco, W. (1998) · Nature Medicine · doi:10.1038/2673 · Cited by 342
Soto, C., Castaño, E. M., Frangione, B., & Inestrosa, N. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.3063 · Cited by 321
Law, A. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00051-5 · Cited by 314
Does insulin dysfunction play a role in Alzheimer's disease?
Gasparini, L. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02037-0 · Cited by 314
Evidence that Alzheimer’s disease is a microvascular disorder: the role of constitutive nitric oxide
de la Torre, J. C., & Stefano, G. B. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00043-6 · Cited by 308
[Apolipoprotein E polymorphism and Alzheimer disease].
van der Weide, J., Steijns, L. S. W., Jl, T., Wj, N., & Klaverwijden, G. (1996) · PubMed · Cited by 297
Xia, M., Qin, S., Wu, L., Mackay, C. R., & Hyman, B. T. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65542-3 · Cited by 292
Rogers, J. T., Leiter, L. M., McPhee, J., Cahill, C. M., Zhan, S.-S., Potter, H., & Nilsson, L. N. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6421 · Cited by 290
Skovronsky, D. M., Doms, R. W., & Lee, V. M.-Y. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.4.1031 · Cited by 290
Generation of antibodies specific for β-amyloid by vaccination of patients with Alzheimer disease
Hock, C., Konietzko, U., Papassotiropoulos, A., Wollmer, A., Streffer, J., von Rotz, R. C., Davey, G., Moritz, E., & Nitsch, R. M. (2002) · Nature Medicine · doi:10.1038/nm783 · Cited by 284
(1997) · Neuroscience · doi:10.1016/s0306-4522(96)00577-5 · Cited by 278
Cybrids in Alzheimer's disease: a cellular model of the disease?
Swerdlow, R. H., Parks, J. K., Cassarino, D. S., Maguire, D. J., Maguire, R. S., Bennett, J. P., Davis, R. E., & Parker, W. D. (1997) · Neurology · doi:10.1212/wnl.49.4.918 · Cited by 272
Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease
Guo, Q., Fu, W., Xie, J., Luo, H., Sells, S. F., Geddes, J. W., Bondada, V., Rangnekar, V. M., & Mattson, M. P. (1998) · Nature Medicine · doi:10.1038/nm0898-957 · Cited by 264
Cybrids in Alzheimer's disease: A cellular model of the disease?
Swerdlow, R. H., & Parker, D. W. (1998) · Neurology · doi:10.1212/wnl.51.1.326-a · Cited by 260
Greenberg, S. M., Briggs, M. E., Hyman, B. T., Kokoris, G. J., Takis, C., Kanter, D. S., Kase, C. S., & Pessin, M. S. (1996) · Stroke · doi:10.1161/01.str.27.8.1333 · Cited by 259
Reactive oxygen species and oxidative DNA damage.
Hemnani, T., & Parihar, M. S. (1998) · PubMed · Cited by 255
Self-citationKimberly, W. T., Xia, W., Rahmati, T., Wolfe, M. S., & Selkoe, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3173 · Cited by 253
Biological markers for therapeutic trials in Alzheimer’s disease
Frank, R. A., Galasko, D., Hampel, H., Hardy, J., de Leon, M. J., Mehta, P. D., Rogers, J., Siemers, E., & Trojanowski, J. Q. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00002-2 · Cited by 252
An analysis of the role of coenzyme Q in free radical generation and as an antioxidant
Beyer, R. E. (1992) · Biochemistry and Cell Biology · doi:10.1139/o92-061 · Cited by 251
Neuroprotection and neurodegenerative disease
Vajda, F. J. E. (2002) · Journal of Clinical Neuroscience · doi:10.1054/jocn.2001.1027 · Cited by 244
Electron Microscopy of Proteins
SHOTTON, D. (1982) · Biochemical Society Transactions · doi:10.1042/bst0100438b · Cited by 241
Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein.
Knauer, M. F., Soreghan, B., Burdick, D., Kosmoski, J., & Glabe, C. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7437 · Cited by 233
Montine, K. S., Olson, S. J., Amarnath, K., Whetsell, W. O., Graham, D. G., & Montine, T. J. (1997) · Europe PMC (PubMed Central) · Cited by 231
Reactive oxygen species and Alzheimer's disease
Multhaup, G., Ruppert, T., Schlicksupp, A., Hesse, L., Beher, D., Masters, C. L., & Beyreuther, K. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00062-2 · Cited by 227
Keller, J. N., Guo, Q., Holtsberg, F. W., Bruce-Keller, A. J., & Mattson, M. P. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-12-04439.1998 · Cited by 215
A Hypothesis on the Pathogenesis of Alzheimer's Disease
Harman, D. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb39059.x · Cited by 213
Caspase-Dependent and -Independent Death of Camptothecin-Treated Embryonic Cortical Neurons
Stefanis, L., Park, D. S., Friedman, W. J., & Greene, L. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-15-06235.1999 · Cited by 200
Increased lipoprotein oxidation in alzheimer’s disease
Schippling, S., Kontush, A., Arlt, S., Buhmann, C., Stürenburg, H.-J., Mann, U., Müller-Thomsen, T., & Beisiegel, U. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00247-6 · Cited by 199
Oxidative Insults Are Associated with Apolipoprotein E Genotype in Alzheimer's Disease Brain
Ramassamy, C., Averill, D., Beffert, U., Theroux, L., Lussier-Cacan, S., Cohn, J. S., Christen, Y., Schoofs, A., Davignon, J., & Poirier, J. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0273 · Cited by 195
Electron Microscopy of Proteins
Cowden, R. R., & Harris, J. R. (1983) · Transactions of the American Microscopical Society · doi:10.2307/3225931 · Cited by 193
Therapeutic strategies for Alzheimer's disease
Wolfe, M. S. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd938 · Cited by 190
Alzheimer's disease and Down's syndrome: roles of APP, trophic factors and ACh
Isacson, O. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02037-4 · Cited by 187
Su, J. H., Deng, G., & Cotman, C. W. (1997) · Brain Research · doi:10.1016/s0006-8993(97)81703-9 · Cited by 175
Decreased base excision repair and increased helicase activity in Alzheimer's disease brain
Lovell, M. A., Xie, C., & Markesbery, W. R. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02335-5 · Cited by 174
Aβ as a bioflocculant: implications for the amyloid hypothesis of Alzheimer’s disease
Robinson, S. R., & Bishop, G. M. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00342-6 · Cited by 172
Functional Aspects of Creatine Kinase in Brain
Hemmer, W., & Wallimann, T. (1993) · Developmental Neuroscience · doi:10.1159/000111342 · Cited by 166
Selective reduction ofN-acetylaspartate in medial temporal and parietal lobes in AD
Schuff, N. W., Capizzano, A. A., Du, A., Amend, D. L., O’Neill, J., Norman, D. M., Kramer, J., Jagust, W. J., Miller, B. L., Wolkowitz, O. M., et al. (2002) · Neurology · doi:10.1212/wnl.58.6.928 · Cited by 143
Jordán, J., Galindo, M. F., Miller, R. J., Reardon, C. A., Getz, G. S., & LaDu, M. J. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00195.1998 · Cited by 139
The female sex hormone oestrogen as a neuroprotectant
Behl, C., & Holsboer, F. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01392-9 · Cited by 134
Competition for Microtubule-binding with Dual Expression of Tau Missense and Splice Isoforms
Lü, M., & Kosik, K. S. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.1.171 · Cited by 131
Mitochondria and free radicals in neurodegenerative diseases
Beal, M. F., Howell, A. N., & Bodis-Wollner, I. G. (1997) · Wiley-Liss eBooks · Cited by 126
Nicholls, D. G., Vesce, S., Kirk, L., & Chalmers, S. (2003) · Cell Calcium · doi:10.1016/s0143-4160(03)00144-1 · Cited by 111
Goldman, J. E., Calingasan, N. Y., & Gibson, G. E. (1994) · Current Opinion in Neurology · doi:10.1097/00019052-199408000-00002 · Cited by 106
Impact of apoE deficiency on oxidative insults and antioxidant levels in the brain
Ramassamy, C., Krzywkowski, P., Averill‐Bates, D. A., Lussier‐Cacan, S., Théroux, L., Christen, Y., Davignon, J., & Poirier, J. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00268-0 · Cited by 105
Molecular basis of Alzheimer's disease
Drouet, B., Pinçon‐Raymond, M., Chambaz, J., & Pillot, T. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050035 · Cited by 103
Parihar, M. S., & Hemnani, T. (2003) · Journal of Biosciences · doi:10.1007/bf02970142 · Cited by 102
Self-citationRelation of Coronary Atherosclerosis and Apolipoprotein E Genotypes in Alzheimer Patients
Kosunen, O., Talasniemi, S., Lehtovirta, M., Heinonen, O., Helisalmi, S., Mannermaa, A., Paljärvi, L., Ryynänen, M., Riekkinen, P. J., & Soininen, H. (1995) · Stroke · doi:10.1161/01.str.26.5.743 · Cited by 102
Oxidative Damage in Neurodegenerative Diseases
Beal, M. F. (1997) · The Neuroscientist · doi:10.1177/107385849700300112 · Cited by 97
Induction of Superoxide Anion and Nitric Oxide Production in Cultured Microgliaa
Colton, C. A., Snell, J. C., Chernyshev, O. N., & Gilbert, D. L. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21789.x · Cited by 94
Parihar, M. S., & Hemnani, T. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-003-0069-8 · Cited by 90
Self-citationAlzheimer's and prion diseases: distinct pathologies, common proteolytic denominators
Checler, F., & Vincent, B. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02263-4 · Cited by 89
Perry, G. L., Taddeo, M. A., Nunomura, A., Zhu, X., Zenteno‐Savín, T., Drew, K. L., Shimohama, S., Ávila, J., Castellani, R. J., & Smith, M. A. (2002) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/s1532-0456(02)00119-9 · Cited by 83
Lee, Y., Aono, M., Laskowitz, D. T., Warner, D. S., & Pearlstein, R. D. (2003) · Neurochemistry International · doi:10.1016/s0197-0186(03)00112-8 · Cited by 80
Age-related toxicity to lactate, glutamate, and β-amyloid in cultured adult neurons
Brewer, G. J. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00091-8 · Cited by 79
Culmsee, C., Bondada, S., & Mattson, M. P. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00008-0 · Cited by 78
Tomita, T., Tokuhiro, S., Hashimoto, T., Aiba, K., Saido, T. C., Maruyama, K., & Iwatsubo, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.33.21153 · Cited by 78
Prasad, K. N., Hovland, A. R., Cole, W. C., Prasad, K. C., Nahreini, P., Edwards‐Prasad, J., & Andreatta, C. P. (2000) · Clinical Neuropharmacology · doi:10.1097/00002826-200001000-00002 · Cited by 75
Smith, M. A., re, L. M. S., Vitek, M. P., Monnier, V. M., & Perry, G. L. (1995) · Nature · doi:10.1038/374316b0 · Cited by 73
N-Acetylcysteine delays age-associated memory impairment in mice: role in synaptic mitochondria
Martínez, M., Hernández, A. I., & Martínez-Banaclocha, N. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02349-5 · Cited by 73
Molecular Genetics of Alzheimer Disease
George‐Hyslop, P. S. (1999) · Seminars in Neurology · doi:10.1055/s-2008-1040852 · Cited by 70
Regulation of Apoptosis by Presenilin 1
Wolozin, B. L., Alexander, P., & Palacino, J. J. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00041-4 · Cited by 60
Apoptosis and expression of DNA repair proteins in ischaemic brain injury in man
Love, S., Barber, R., & Wilcock, G. K. (1998) · Neuroreport · doi:10.1097/00001756-199804200-00001 · Cited by 60
Characterization of 8‐Epiprostaglandin F2α as aMarker of Amyloid β‐Peptide‐Induced Oxidative Damage
Mark, R. J., Fuson, K. S., & May, P. C. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721146.x · Cited by 54
Secretases as targets for the treatment of Alzheimer’s disease
Citron, M. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(00)01759-7 · Cited by 53
A Textbook of Pathology. An Introduction to Medicine
(1938) · Physical Therapy · doi:10.1093/ptj/18.4.228 · Cited by 49
Cholinergic Markers in Alzheimer Disease
Bartus, R. T., & Emerich, D. F. (1999) · JAMA · doi:10.1001/jama.282.23.2208 · Cited by 49
Pathogenic theories and intrathecal analysis of the sporadic form of Alzheimer’s disease
Torreilles, F., & Touchon, J. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00030-2 · Cited by 48
Lee, E.-J., Ayoub, I. A., Harris, F., Hassan, M. U., Ogilvy, C. S., & Maynard, K. I. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991101)58:3<387::aid-jnr4>3.0.co;2-l · Cited by 44
Mitochondria and Free Radicals in Neurodegenerative Diseases
Swerdlow, R. H. (1998) · The American Journal of Human Genetics · doi:10.1086/302091 · Cited by 44
ApoE associated with lipid has a reduced capacity to inhibit β-amyloid fibril formation
Beffert, U., & Poirier, J. (1998) · Neuroreport · doi:10.1097/00001756-199810050-00031 · Cited by 41
Paris, D., Town, T., Parker, T. A., Humphrey, J., & MULLAN, M. J. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00764-2 · Cited by 39
Müller, U., & Kins, S. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02320-1 · Cited by 35
Bano, S., & Parihar, M. S. (1997) · Journal of Neural Transmission · doi:10.1007/bf01294728 · Cited by 31
Self-citationClassification of amyloid fibril proteins and their precursors: An ongoing discussion
Westermark, P. (1997) · Amyloid · doi:10.3109/13506129709014387 · Cited by 29
Does mitochondrial respiratory chain dysfunction have a role in common neurodegenerative disorders?
Byrne, E. (2002) · Journal of Clinical Neuroscience · doi:10.1054/jocn.2001.0991 · Cited by 26
Apolipoprotein E-Related Neurotoxicity as a Therapeutic Target for Alzheimer's Disease
Marques, M. A., & Crutcher, K. A. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:3:327 · Cited by 19
Gene expression profile in Alzheimer’s brain screened by molecular indexing
Doyu, M., Sawada, K.-I., Mitsuma, N., Niwa, J., Yoshimoto, M., Fujii, Y., Sobue, G., & Kato, K. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00223-0 · Cited by 15
Metabolism of Presenilin 1: Influence of Presenilin 1 on Amyloid Precursor Protein Processing
Borchelt, D. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00026-8 · Cited by 8
Imaging Alzheimer's disease in vivo: not so ‘implaque-able’ anymore
Leslie, R. A. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02160-4 · Cited by 8
Frantz, S. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd931 · Cited by 1
Cited by
Dong, X.-X., Wang, Y., & Qin, Z.-H. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.24 · Cited by 1,297
Ma, X., & Gang, D. R. (2004) · Natural Product Reports · doi:10.1039/b409720n · Cited by 649
Agrawal, M., Saraf, S., Saraf, S., Antimisiaris, S. G., Chougule, M. B., Shoyele, S. A., & Alexander, A. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.011 · Cited by 630
Real-time shape approximation and fingerprinting of single proteins using a nanopore
Yusko, E. C., Bruhn, B. R., Eggenberger, O. M., Houghtaling, J., Rollings, R. C., Walsh, N. C., Nandivada, S., Pindrus, M., Hall, A. R., Sept, D., et al. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2016.267 · Cited by 473
Pharmacologic overview of Withania somnifera, the Indian Ginseng
Dar, N. J., Hamid, A., & Ahmad, M. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2012-1 · Cited by 370
Metadata
- Authors
- Parihar, M. S., & Hemnani, T.
- Venue
- Journal of Clinical Neuroscience
- Publisher
- Elsevier BV
- Published
- 2004-06
- Volume
- 11
- Issue
- 5
- Pages
- 456-467
- ISSN
- 0967-5868 (ISSN-L)
- OpenAlex
- W2160383632
- Cited by
- 433
- References
- 127
- FWCI
- 7.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.